Hovione commits $35 million to integrated U.S. continuous tableting
Company / institutional announcement · Hovione
Source published:
Site published: 2026-11-03 · Updated: 2026-11-03
This source is linked automatically. Choose a question to get started.
What changed
Hovione plans to install a $35 million ConsiGma CDC Flex line at its East Windsor, New Jersey, campus, with commissioning expected in late 2027. The system will link spray-dried amorphous solid dispersions to tablet production under one quality system. Planned continuous and batch modes span 1 to 200 kilograms per hour, with development possible using 1.5 kilograms.
Why it may matter
Integrating solubility enhancement with downstream tableting could reduce handoffs, while claims of avoiding traditional scale-up still require product-specific validation data.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections